American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
38 hedge funds and large institutions have $134M invested in American Oncology Network, Inc. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$15.2M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$9.8M |
| 3 |
Goldman Sachs
New York
|
+$7.42M |
| 4 |
HI
HBK Investments
Dallas,
Texas
|
+$7.34M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$6.36M |
Top Sellers
AONC Hedge Fund Activity: Q2 2021 in Review
38 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q2 2021, worth a combined $134M.
Buyers outnumbered sellers: 38 funds opened new AONC positions and 0 closed out — a net gain of 38 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Weiss Asset Management, opening a new position worth an estimated $15.2M.
- 38 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $134M of American Oncology Network, Inc. Class A Common Stock stock for Q2 2021.
- 38 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q2 2021 and 0 closed out, a net change of +38 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q2 2021 was Weiss Asset Management, an estimated $15.2M added.
Based on aggregated 13F filings for Q2 2021.